Novo Nordisk shares plunge on the back of disappointing trial results
Novo Nordisk shares have plunged 20% amid the disappointing trial result of its latest weight-loss drug CagriSema. The fall wiped ...
Tag: Weight Loss
Visceral fat found to contribute to Alzheimer's disease development
Researchers have linked a specific type of body fat to the abnormal proteins in the brain that are hallmarks of ...
Nearly half of weight loss participants reduced alcohol use after starting anti-obesity medication
Anti-obesity medications linked to reduced alcohol use, possibly due to effects on cravings and reward systems, with behavioral strategies also ...
Can fasting improve diabetes outcomes? Ramadan offers insights
Discover how religious fasting reveals powerful yet fleeting health benefits, emphasizing the importance of consistent dietary strategies for managing type ...
Primary care clinicians key to achieving optimal cardiovascular health
Primary care clinicians and practices are uniquely positioned to help people achieve optimal cardiovascular health through screening, diagnosing and treating ...
Study reveals liver-brain communication as key to managing circadian eating patterns and obesity
Research highlights the hepatic vagal nerve’s role in regulating food intake rhythms, offering new insights for potential anti-obesity treatments. Study: Hepatic ...
Weight loss drug semaglutide may offer relief for knee arthritis pain
New research highlights the potential for weight-loss medication to ease arthritis symptoms, offering hope for improved mobility and pain relief. ...
Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity
The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. ...
Semaglutide improves heart health and reduces weight in obese patients, but with side effects
Study shows that semaglutide not only aids in weight loss but also slashes heart failure risk by 76% in overweight ...
Semaglutide cuts death rates from cardiovascular disease and COVID-19
Patients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, ...
